Does gemcitabine-based combination therapy improve the prognosis of unresectable pancreatic cancer?

Abstract

AIM To assess whether gemcitabine-based combination therapy improves the prognosis of unresectable pancreatic cancer compared with gemcitabine treatment alone. METHODS A quantitative up-to-date meta-analysis was undertaken to investigate the efficacy of gemcitabine-based combination treatment compared with gemcitabine monotherapy in locally advanced or… (More)

Topics

  • Presentations referencing similar topics